CompletedNot Applicable

Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women

United States10 participantsStarted 2008-01

Plain-language summary

The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female seeking abortion services * Less than or equal to 12 weeks gestation * Age 18-50 * Willing and able to sign informed consent * Use of Coumadin or LMW heparin (treatment group only) Exclusion Criteria: * Unwilling or unable to sign informed consent * Women taking daily aspirin or herbal therapies containing gingko biloba * Women with a known history of a bleeding disorder such as von willebrand's disease

What they're measuring

Volume of Intraoperative Blood Loss

Timeframe: Post procedure

Trial details

NCT IDNCT00614432

SponsorUniversity of Hawaii

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-04

Results submitted2018-05-22

View on ClinicalTrials.gov More Blood Loss trials